Yazar "Buyukberber, S." seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial(Amer Soc Clinical Oncology, 2011) Yalcin, S.; Uslu, R.; Dane, F.; Yilmaz, U.; Zengin, N.; Buyukunal, E.; Buyukberber, S.; Camci, C.; Sencan, O.; Kilickap, S.Öğe Interim results of observational study to determine K-ras mutation rates in patients with metastatic colorectal cancer in Turkey (TURKRAS study)(Elsevier Sci Ltd, 2013) Gumus, M.; Dane, F.; Karabulut, B.; Uygun, K.; Orhan, B.; Aydin, K.; Buyukberber, S.; Okutur, S. K.; Unek, T.; Ozen, R. S.Öğe MIPI-TURK - Multicentric Ipilimumab Experience in Turkish Patients With Metastatic Melanoma(Elsevier Sci Ltd, 2011) Sevinc, A.; Ozdogan, M.; Buyukberber, S.; Aydin, F.; Mandel, N. M.; Demir, O. G.; Gokmen, E.; Arpaci, F.; Paydas, S.; Celik, I.Öğe Multicentric Ipilimumab Experience in Turkish Patients with Metastatic Melanoma: MIPI-TURK at 3 years(Wiley-Blackwell, 2013) Sevinc, A.; Turna, H.; Ozdogan, M.; Buyukberber, S.; Demir, G.; Gokmen, E.; Mandel, N. M.; Paydas, S.; Akbulut, H.; Celik, I.Öğe A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer(Amer Soc Clinical Oncology, 2011) Yalcin, S.; Uslu, R.; Dane, F.; Yilmaz, U.; Zengin, N.; Buyukunal, E.; Buyukberber, S.; Camci, C.; Sencan, O.; Kilickap, S.
